Inhibitors of Catechol-O-Methyltransferase

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 324-332

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[ 18 F]l-DOPA

By Doudet D.J.   Chan G.L.Y.   Holden J.E.   Pate B.D.   Morrison K.S.   Calne D.B.   Ruth T.J.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study

By Malagie I.   Trillat A.-C.   Jacquot C.   Gardier A.M.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 213-217

Elsevier

Access to resources Recommend Favorite

BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of l-DOPA to the brain and reduces its O-methylation

By Parada A.   Loureiro A.I.   Vieira-Coelho M.A.   Hainzl D.   Soares-da-Silva P.  

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite